chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills, low-grade fever, muscle aches all over, weakness, nausea which started approximately 9 to 10 hours after receiving the vaccination. The symptoms continued through the night and began resolving the next day.
pt states arm hurt from time pneumovax given till got home;pt applied ice to area;20OCT97 arm red & swollen to elbow-chills 19OCT97 & 20OCT97;h/a, pain in neck, arm warm to touch;eval by MD 20OCT97;22OCT97 pt states redness, soreness better
Anaphylaxis, CoughWheeze & UrticariaPruritus History of asthma, Epipen given with good improvement.
Pelvic Inflammatory Disease; Now I have Postural Orthostatic Tachycardia Syndrome; I had ovarian pain that made it miserable to walk; I also contracted HPV one year after receiving vaccination; I felt sick; fatigued; had a foggy memory; severe joint pain; flu-like symptoms; "I fainted after the first dose; This spontaneous report has been received from a non pregnant 19 year old female patient  with sulfa allergy (reported as "sulpha"), concerning herself. The patient had not medical history and was not taking any concomitant medications.      In May or June 2010,  the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) intramuscularly in the left arm (lot number and expiration date were not reported) for prophylaxis.         In May or June 2010, after received the first dose of  hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) the patient fainted (syncope). For two weeks afterwards, she felt sick (malaise), fatigued, she was in bed all the time, had a foggy memory(memory impairment), severe joint pain  (arthralgia), and flu-like symptoms. The patient received the other two doses of of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) on unspecified dates, and this happened every time after she received the vaccine.  One year after received the vaccination, in 2011, the patient contracted human papilloma viral infection (HPV).  On an unspecified date, the patient started to experience postural orthostatic tachycardia syndrome, pelvic inflammatory disease, and ovarian pain that made it miserable to walk.   The patient had visited multiple physicians for medical attention and unspecified blood tests had been performed (results not reported); however, the patient had not received any treatment for the adverse events. She stated "I need to be tested for lupus and rheumatoid arthritis"; however, not further information was provided.  At the reporting time, the patient was recovered from malaise, influenza like illness, arthralgia, memory impairment and fatigue; however, she had not recovered from pelvic inflammatory disease and postural orthostatic tachycardia syndrome. The outcome of syncope, ovarian pain and papilloma viral infection was unknown. .        Causality assessment between the events and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) was not provided.  Upon internal review, the events of faint and pelvic inflammatory disease were considered to be medically significant.
Received ZOSTAVAX injection on 9/25/2009. Had no history of allergic reaction to gelatine or any antibiotic. Initial reaction at injection site 24 hrs. following injection were: an area about 3 in. around was red, burning, swollen with jabbing pains and hot to touch. It kept me awake for about three nights the pain was that severe. Kept putting cold compresses on area.  After nine days the area was back to normal.  On day 13 following the injection, I awoke with the feeling I was coming down with the flue; tired, head achey, stiff neck and general malaise. The next morning, day 14, I awoke to find the beginnings of a slight rash and I felt worse than the day before. By that night as I was getting ready for bed, I noticed the rash had spread down my left side from below my arm pit to almost the groin area. I have the shingles! 180 days later, I have the shingles!
Intense stomach cramps; This is a spontaneous report from a contactable healthcare professional. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes. The patient had known allergies to sulphate and latex. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included furosemide (MANUFACTURER UNKNOWN), insulin (MANUFACTURER UNKNOWN), thyroid (ARMOUR THYROID) and potassium (MANUFACTURER UNKNOWN), all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 11Mar2021 at 13:00, the patient experienced intense stomach cramps. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the event stomach cramps was not recovered at the time of report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Patient reported mild dizziness and chest tightness Patient stated she received moderna 3/10/21 and had similar worse symptoms and was told by her provider to get Johnson and Johnson  Patient seen by medical team, vitals were stable and sinus rhythm and advised to go to hospital but patient refused and signed AMA form Patient driven home by spouse
This spontaneous report was received from a healthcare worker refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 15-FEB-2016, the patient was vaccinated with an expired dose of MMR II lot # K001230, expiry date 26-JAN-2016, 0.5 ml, subcutaneous. No adverse effects were reported. The outcome of the events was unknown. No product quality complaint (PQC) was involved. Additional information has been requested.
Develop chest pain and pressure. Negative troponins. Given ASA 80mg po and 60mg Lovenox SC. Given Nitro tab with relief. O2/NC.
my left breast started draining clear/white fluid; there is associated pain radiating down towards the nipple from the top of the breast and along the left side of the breast; This is a spontaneous report from a contactable nurse who reported for herself   This  44-years-old female patient received the second dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) from lot# EL3247 in the left arm on 19Jan2021 at SINGLE DOSE for covid-19 immunization . Facility where the most recent COVID-19 vaccine was administered:Workplace clinic.Age at vaccination 44 years.The patient received the first dose of the same vaccine from Lot # EL1284 on 29Dec2020 via intramuscular , on the Left arm .Tthe patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included hypothyroidism , gestational diabetes ,Allergies: Bees (anaphylaxis) , Allergy: shrimp (gastrointestinal) .Concomitant medication included levothyroxine ,  alprazolam  , procaterol hydrochloride (PRO-AIR), chlorphenamine maleate (CHLOR)  and vitamin d . The patient reported as follows :"On 22Jan2021 18:00 my left breast started draining clear/white fluid. Additionally there was associated pain radiating down towards the nipple from the top of the breast and along the left side of the breast that has lasted two weeks and continues".Lab data included mammogram (2021): unknown results .ultrasound left breast (2021): unknown results.The adverse event result in Doctor or other healthcare professional office/clinic visit.Events were treated (I have had to have a mammogram and ultrasound of left breast and am awaiting an MRI.Levaquin ).Events reported as non serious.Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, has the patient been tested for COVID-19.Outcome of the events was not recovered.
Patient complained of chest tightness and was observed to be red in the face arms, chest, and neck.
Information was received on 09-NOV-2016 from an unspecified reporter, regarding a patient of unknown age and gender. The patient's medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB (strength, dose and route were not reported) with lot number M007763 (unspecified expiration date). No adverse experiences were reported. This is one of several reports received from the same reporter. Additional information is not expected.
After almost 2 weeks since my first injection, the site became reddened and itchy.
sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "sore arm". Therapeutic measures were taken as a result of pain in extremity.  Additional information: It was reported that i took both of the Pfizer Covid shots. I experienced a sore arm after the vaccination. I  was took two Tylenol tablets and the pain went away. I am receiving my Covid booster shot today.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Initial unsolicited report received from a physician on 09 February 2016. This case involves a 58-year-old female patient who was vaccinated with a dose of YELLOW FEVER VACCINE (batch number: UI080AA) (expiry date, dose, dose in series, route of administration were not reported) in left deltoid; with first dose of Vivotif via oral route (batch number, manufacturer: Pax Vax, expiry date, dose, dose in series, and site of administration were not reported) on 08 February 2016. Illness at time of vaccination, any other vaccinations within 4 weeks of vaccinations reported as none and pre-existing physician diagnosed allergies, birth defects, medical conditions reported as NKA, HX Diabetes Oral. Concomitant medications were not reported. On 08 February 2016, same day after Yellow fever vaccine and within about 01 hour after taking Typhim pill, the patient developed neck pain and pain down her left leg. On an unknown date, the patient was unable to bear weight on her left leg due to the pain. She was on the way to the emergency room at Hospital. He was awaiting a call from the Emergency room. The patient required ER/doctor visit. The patient's laboratory data and corrective treatment was not reported. The patient was not recovered from the event. List of documents held by sender: none.
Information has been received from a physician concerning a  33 year old Asian female with no past medical history who on 02/09/2001 at 10:45 was vaccinated with a first dose of Varicella virus vaccine live, There was no concomitant medication or illness at the time of vaccination. On 02/21/2001, the patient was seen by a physician who noted Varicella lesions at the injection site with appeared as a red rash. The patient's experience was considered to be disabling by the reporter as the patient was unable to work from 02/21/2001- until 02/27/2001 since she is a registered nurse and was not allowed to have patient contact. On 02/27/2002, the patient recovered. No further information is expected.
Inability to think clearly/slowed reaction time/knowing the right steps to do a process but unable to execute timely or well Chills/freezing/cold sweats Nausea, GI distress Dizziness/lightheaded/feelings of severe dehydration/feeling unstable on feet Anterior chest burning
A 35-year-old female patient received an injection of pneumococcal vaccine on 06/27/06. On 06/28/06, at 0300 in the morning, 13 hours after the pneumococcal vaccine was administered, the patient complained of severe muscular pain in the right shoulder at the site of injection. The patient had not previously complained of any pain. Tylenol was administered to the patient as a rescue medication for the pain. No laboratory or diagnostic testing was done.
Paralysis in arm and leg. Mostly in first 48 hours, then symptoms decreased.
Woke up the morning after the flu vaccine with shoulder and neck pain (right) she took Ibuprofen with some relief. On 10-21-15 she went to Employee Health. Treatment included cold and heat therapy with OTC anti-inflammatory medication as indicated on the bottle.
soreness for a couple of days, it was just like where he got the shot; soreness in the hand; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "recovered", described as "soreness for a couple of days, it was just like where he got the shot"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "soreness in the hand".  Additional information: Soreness for a couple of days, it was just like where he got the shot. The reporter stated he just has a small question, he just wanted to check. The reporter stated after taking the vaccination, there was soreness in the hand. He asked can they use any pain killers or just use Tylenol. The patient verified it was the Pfizer Covid Vaccine he received. The patient stated he did have some soreness for a couple of days, it was just like where he got the shot, he felt some kind of soreness. The patient stated it started a couple of days and just went off and he is good now, he got it last week. The patient stated he just wanted to check on the medication, they said at the pharmacy they can take Tylenol. The patient asked is anything good or just Tylenol, he just wanted to check on the medication.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
On 3/1/22 patient had stomach discomfort and muscle soreness/stiffness. On 3/2/22 muscle stiffness continued, especially in neck.  Began feeling fatigued around midday, took a 2 hour nap and awoke with fever.  On 3/3/22 symptoms continued and fever rose to 104.  Took him to walk-in urgent care where he tested negative for flu and covid and was sent home.  Vomited later that afternoon.  Also woke around 1:00 am with vomit/diarrhea.  Went back to sleep but when he awoke the morning of 3/4/22, rash was present on legs, buttocks, arms, and fever spiked to 106.  Returned to the same clinic and they admitted him to the ER side where they gave him fluids and performed more tests, all of which were negative.  Dr. decided to treat for strep and gave him antibiotics intravenously. Also prescribed antibiotics to continue at home (he was able to take 1 dose at home but wasn't able to keep subsequent dose down). He started feeling better that afternoon and was able to eat/drink a little, but had vomit/diarrhea again at bedtime. Woke around midnight with vomit/diarrhea and again on the morning of 3/5/22, so we took him to the ER at Hospital. Very dehydrated. Bloodwork showed high inflammation throughout entire body. High heart rate with low blood pressure. Chest x-ray and Echo looked normal. Doctor conversed throughout the day with the Infectious Disease Specialist at the Hospital, and they both felt like symptoms pointed to MIS-C.  They helicoptered him that night to the PICU in where doctors ran tests to rule out infection from meningitis, tick-related illness, etc. By 3/6/22 another Echo showed trouble with heart.  By that afternoon he was starting to show occasional mental confusion and mild hallucinations. Infection was ruled out, diagnosis of MIS-C confirmed, and they started IVIG treatment by 3/7/22 at which time symptoms began to slowly dissipate.
See narrative attached. Patient presented to the County Public Health Office for immunizations with her mother. The child appeared well nourished and alert. Patient reacted appropriately to the immunizations and was not upset upon leaving the immunization room around 11:30 a.m. Upon the initial interview with the mother, she noted that patient had had one seizure in April 2011 and had a neurologic work up with no abnormal findings and is not on any medication for seizures. Mother noted that patient is on a maintenance dose of SEPTRA for UTI's and is allergic to OMNICEF. As the mother sat in the waiting room initially after the immunization of Hepatitis A and flu she started to read her a book and mother reported patient's eyes rolled back, she became stiff, her back was arched and her arms extended. She called for attention that patient was having a seizure. APN immediately responded to the mother's call and at that time the mother was holding her daughter. Mother was awake and responsive. The child was carried to the exam room by APN and 911 contacted. The child did not display any seizure activity, was responsive and interacted appropriately with her mother. Mother reported that the child had eaten breakfast. The EMT's arrived at around 11:39 AM and the child was transferred to Community Hospital with her mom, per ambulance by the EMT's. RN was contacted per phone and she stated we needed to fill out a VAERS and a PHN incident report. A copy of the VAERS was faxed to RN. In the afternoon mom brought in her other daughter for immunization and reported there were no abnormal findings per Community Hospital ER. A release of information was signed by mom and faxed to community hospital.
At 14 days after injection I noticed my arm was getting really sore again  about three inches below the injection site.  I have a three inch by three inch red patch that feels warm to the touch.  Not a rash. It has throbbed and been very sore to touch.  It has persisted for about three days now.
Dizziness, Headache, Arthralgia, FATIGUE, LOSS OF TASTE Narrative:
Shock type pain at time of vaccination. Bruising and severe pain immediately following vaccination and continuing into the next day. Inability to lift arm.
Intussusception.  Surgical correction in June 2007. Hospital record for transfer facility rec'd for DOS 6/17-20/2007. Infant transfered to facility for surgical reduction of Intussusception which was non-reduceable by contrast enema.  Child presented at first facility with 1 day hx of grossly bloody, watery stools with mucus and one episode of emesis.  Child has been fussy. PE WNL. Barium contrast enema attempted to reduce IS but was unsuccessful.  Infant had an Exploratory Lap, reduction of IS and small bowel resection with primary reanastomosis. DX: Intussusception. F/U visit 7/13/2007 with report of some fussiness since the surgery but otherwise healing well.
pain in lt deltoid began the next day & radiated up to neck;stiff neck for 24hr;tx w/Ibuprofen;resolved p/24hr;
Tested positive; Tested positive; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). A 31-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 15Dec2022 as dose 3 (booster), single (Lot number: GJ6742) at the age of 30 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 19Feb2021 as dose 1, single (Lot number: EN6200) and on 18Mar2021 as dose 2, single (Lot number: EP7534) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 10Jan2023, outcome "unknown" and all described as "Tested positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (10Jan2023) Positive.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the information provided in the narrative, a causal association between the events and the suspect drug cannot be completely excluded.
Rhinorrhea; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 77-year-old patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RHINORRHOEA (non-serious), outcome "unknown", described as "Rhinorrhea".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient had her 3rd dose of Hepatitis B vaccine on 1-8-03.  On 1-14-03 she had a seizure in the evening.  She had another on 1 -17-03.  She was brought in and we were told at the time that it was infantile spasms.  On 2-22-03 we rushed her to the emergency room where they told us she has Epilepsy.  When we asked the doctors about the possible relationship to the vaccine they told us that they were not related. Per follow up report received on 06/09/2005:  Patient continues to have seizures on occasions and is also developmentally delayed. Per follow up report-continues to have seizures. Recently diagnosed with Autism. Severe developmental delays. Patient has many food and medication allergies. Was happy and developed normally until this vaccine. Something needs to be done so this doesn't happen to more innocent kids.
itchy; Papules; rash patient experienced looked like chickenpox/blistery rash; pain; redness; Felt like could not move arm; hardness; This case was reported by a nurse via call center representative and described the occurrence of injection site pain in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd July 2019, the patient received the 1st dose of Shingrix. On 23rd July 2019, immediately after receiving Shingrix, the patient experienced injection site pain, injection site erythema, injection site induration and injected limb mobility decreased. On 29th July 2019, the patient experienced pruritus, papular rash and varicella-like rash. On an unknown date, the outcome of the injection site pain, injection site erythema, injection site induration, injected limb mobility decreased, pruritus, papular rash and varicella-like rash were unknown.   It was unknown if the reporter considered the injection site pain, injection site erythema, injection site induration, injected limb mobility decreased, pruritus, papular rash and varicella-like rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the 1st dose of Shingrix. Shortly afterward the patient reported local reaction (pain, redness, and hardness) and felt like could not move arm. On 29th July 2019, the patient experienced broke out in a rash-blisters papules itchy on arms, trunk and back,  The reporter consented to follow up. This case has been linked with case US2019139552, reported by the same reporter. The case US2019AMR139399 is identified as duplicate case of US2019139548. The case US2019AMR139399 would be deleted and the US2019139548 will be the case of record for the communications.